Ada Health Assessment (AI symptom assessment & care navigation)
Ada Health · Digital front door, patient portal, telehealth, government health programs · SaaS / API, white-label and embedded in patient portals (Epic App Orchard)
Clinical Evidence & Decision Support
Ada is an AI-powered symptom assessment and care navigation platform that guides patients through a conversational intake to understand their symptoms and recommend appropriate next steps. It combines probabilistic reasoning with an expert-curated medical knowledge base and deploys at enterprise level across health systems, payers, and governments, including inside patient portals such as Epic MyChart.
Evidence at a glance
Freshness, source-checked counts, confidence and gate results below reflect the frozen evidence snapshot through . A later editorial review does not update these results.
- Stated intended users
- Health systems, payers/insurers, governments, and life sciences organizations
- Documentary gate at snapshot
- Failed
- Scenario match
- No evaluated buying scenario currently covers this product
- Comparability
- Not yet comparable in this scenario
- Decision readiness at snapshot
- HISTORICAL — Research only
- Documented evidence at snapshot
- 0 of 4 evidence claims source-checked · confidence Low
- Critical unknowns
- scaled production deployment · security and governance evidence · documented economic outcomes
- Latest checked-source retrieval in snapshot
- not yet measured
Expand each claim to inspect its source, dates and recorded verification status.
peer reviewed studyPeer-reviewed Nature Health study (SAFEMOM) of Ada integrated into South Africa's government-run MomConnect WhatsApp maternal health platfor…2026-06-30
Exact claim. Peer-reviewed Nature Health study (SAFEMOM) of Ada integrated into South Africa's government-run MomConnect WhatsApp maternal health platform found safe health-seeking behavior rose nearly a third and appropriate care-seeking rose more than 40%; an independent physician panel rated Ada's recommendations safe in 98% of cases
- Source
- doi.org
- Type
- peer reviewed study
- Published
- 2026-06-30
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- evidence_strength
- Score contribution
- Feeds evidence strength
Peer-reviewed. Check population, setting, and applicability to your workflow before generalizing.
Open doi.orgpress releaseAda's medical AI solutions are available on the Epic App Orchard marketplace using SMART on FHIR open standards, with single sign-on (SSO) s…2022-03-15
Exact claim. Ada's medical AI solutions are available on the Epic App Orchard marketplace using SMART on FHIR open standards, with single sign-on (SSO) supporting integration into MyChart patient portals
- Source
- about.ada.com
- Type
- press release
- Published
- 2022-03-15
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- interoperability
- Score contribution
- Feeds interoperability
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open about.ada.compress releaseAda closed its Series B at $120M: $90M led by Leaps by Bayer (May 2021) plus a $30M extension from Farallon Capital, Red River West and Bert…2022-02-10
Exact claim. Ada closed its Series B at $120M: $90M led by Leaps by Bayer (May 2021) plus a $30M extension from Farallon Capital, Red River West and Bertelsmann Investments (Feb 2022), with Schroders Capital acquiring secondary shares; total funding ~$189M
- Source
- about.ada.com
- Type
- press release
- Published
- 2022-02-10
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- market_durability
- Score contribution
- Feeds market durability
Vendor or press announcement. Verify material claims against primary filings or contracts.
Open about.ada.compeer reviewed studyIndependent BMJ Open peer-reviewed vignette study (Gilbert et al., 2020) compared digital symptom assessment apps, including Ada, against GP…2020-12-31
Exact claim. Independent BMJ Open peer-reviewed vignette study (Gilbert et al., 2020) compared digital symptom assessment apps, including Ada, against GPs for suggesting conditions and urgency advice
- Source
- pmc.ncbi.nlm.nih.gov
- Type
- peer reviewed study
- Published
- 2020-12-31
- Retrieved
- 2026-08-27
- Verification
- unverified
- Confidence
- not stated
- Reviewer
- healthit-gate-v1
- Claim version
- v1
- Supports
- evidence_strength
- Score contribution
- Feeds evidence strength
Peer-reviewed. Check population, setting, and applicability to your workflow before generalizing.
Open pmc.ncbi.nlm.nih.govVerified provider experience is not yet publishable. Fewer than five independent provider organizations have contributed eligible reviews. Reviewer mode is off. Experience never changes documentary scoring, freshness, or rank.
Buyer lenses — evidence-backed bands at snapshot (not a 0–100 rank)
Deployment, integration, data handling at snapshot
- Integration maturity
- live — Listed on an EHR marketplace/partner program — live distribution.
- EHR path
- Epic
- FHIR / API
- Documented
- SSO
- Supported
- PHI / BAA
- Enterprise deployments integrate PHI from EHRs (e.g., MyChart) via SMART on FHIR under health-system data agreements; EU entity operating under GDPR-aligned practices
- Security attestations
- UNKNOWN
- FDA status
- UNKNOWN
Why unknown
Why. No FDA listing found for this product's functions in the tracked category.
What would close it. An FDA 510(k)/De Novo listing, or a clear statement that no regulated function is claimed.
- Pricing
- Not publicly listed
Technical provenance
snap_36bba25c577cbb44 · Evidence cutoff: 2026-08-27T04:05Z · Snapshot generated: 2026-10-21T19:39Z · build ffbf5c3
Forecast calibration is not in the public snapshot — shown as UNKNOWN rather than read from SQLite.
Known limitations
- Deployment traction is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Trust & governance is UNKNOWN.
Why unknown
Why. No reliable source on file. The platform does not infer values from weak sources.
What would close it. A primary source or independent verification.
- Economic value evidence is UNKNOWN.
Why unknown
Why. No independently verifiable ROI claim (peer-reviewed, audited case, or independent benchmark) is on file.
What would close it. An audited implementation report or peer-reviewed study with payback/throughput numbers.